Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) – Global Forecast to 2022

◆상품코드 : MAM-MD-5831
◆발행일 : 2017년 12월
◆페이지수 : 183
◆보고서 형식 : PDF / 영문
◆납품 방식 : E메일
◆조사대상 지역 : 글로벌
◆산업분야 : 의료기기
◆발행회사(조사회사) : MarketsandMarkets
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥638,450 -> 환산 ₩6,384,500견적의뢰/구매/질문FORM
Multi User (Five User)¥751,450 -> 환산 ₩7,514,500견적의뢰/구매/질문FORM
Corporate License¥920,950 -> 환산 ₩9,209,500견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

“The blood glucose monitoring system market projected to grow at a CAGR of 4.8%.”
The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.

By patient care setting, the self/home care segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.

“By application, the type 1 diabetes segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.
The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.

“North America to witness the highest growth during the forecast period (2017-2022)”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).`
Research Coverage:
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, application
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the blood glucose monitoring system market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various blood glucose monitoring system across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the blood glucose monitoring system market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the blood glucose monitoring system market

[조사보고서 목차]

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DESIGN 20
2.2 RESEARCH APPROACH 21
2.2.1 SECONDARY RESEARCH 22
2.2.2 PRIMARY RESEARCH 23
2.3 MARKET SIZE ESTIMATION 26
2.4 MARKET DATA VALIDATION AND TRIANGULATION 28
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS: MARKET OVERVIEW 35
4.2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT 35
4.3 GEOGRAPHIC ANALYSIS: GLOBAL SELF-MONITORING/ TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT 36
4.4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT 37
4.5 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING 37
4.6 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION 38
4.7 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE 38
4.8 GEOGRAPHIC SNAPSHOT: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Growing prevalence of diabetes 41
5.2.1.2 Increasing number of product launches 42

5.2.2 RESTRAINT 43
5.2.2.1 High cost and poor reimbursement of blood glucose monitoring systems and supplies 43
5.2.3 OPPORTUNITY 43
5.2.3.1 Pipeline products and ongoing research 43
5.2.4 CHALLENGE 44
5.2.4.1 Invasiveness of blood glucose monitors 44
6 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT 45
6.1 INTRODUCTION 46
6.2 SELF-MONITORING BLOOD GLUCOSE SYSTEMS 47
6.2.1 BLOOD GLUCOSE METERS 48
6.2.2 TESTING STRIPS 49
6.2.3 LANCETS & LANCING DEVICES 50
6.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS 53
6.3.1 SENSORS 54
6.3.2 TRANSMITTERS 55
6.3.3 RECEIVERS 56
7 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE 57
7.1 INTRODUCTION 58
7.2 FINGERTIP TESTING 59
7.3 ALTERNATE SITE TESTING 60
8 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING 61
8.1 INTRODUCTION 62
8.2 SELF/HOME CARE 63
8.3 HOSPITALS & CLINICS 64
9 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 DIABETES 67
9.2.1 TYPE 2 DIABETES 67
9.2.1.1 Adults 68
9.2.1.2 Pediatrics 69
9.2.2 TYPE 1 DIABETES 69
9.2.2.1 Adults 70
9.2.2.2 Pediatrics 71
9.2.3 GESTATIONAL DIABETES 72

10 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION 73
10.1 INTRODUCTION 74
10.2 NORTH AMERICA 75
10.2.1 US 79
10.2.2 CANADA 84
10.3 EUROPE 88
10.3.1 GERMANY 92
10.3.2 UK 96
10.3.3 FRANCE 99
10.3.4 REST OF EUROPE (ROE) 102
10.4 ASIA PACIFIC (APAC) 106
10.4.1 CHINA 110
10.4.2 INDIA 113
10.4.3 JAPAN 116
10.4.4 REST OF APAC 119
10.5 REST OF THE WORLD (ROW) 124
11 COMPETITIVE LANDSCAPE 130
11.1 OVERVIEW 130
11.2 MARKET SHARE ANALYSIS 130
11.2.1 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET 130
11.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET 132
11.3 COMPETITIVE SCENARIO 134
11.3.1 PRODUCT LAUNCHES AND APPROVALS 135
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS 135
11.3.3 EXPANSIONS 136
11.3.4 ACQUISITIONS 137
12 COMPANY PROFILES 138
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 ABBOTT LABORATORIES 138
12.2 F. HOFFMANN-LA ROCHE 141
12.3 LIFESCAN 144
12.4 ASCENSIA DIABETES CARE 146
12.5 DEXCOM 148
12.6 MEDTRONIC 152
12.7 YPSOMED 155
12.8 B. BRAUN MELSUNGEN 157
12.9 NIPRO 159
12.10 SANOFI 161
12.11 ARKRAY 163
12.12 PRODIGY DIABETES CARE 165
12.13 ACON LABORATORIES 166
12.14 NOVA BIOMEDICAL 168

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 170
13.1 DISCUSSION GUIDE 170
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 176
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 178
13.4 AVAILABLE CUSTOMIZATIONS 179
13.5 RELATED REPORTS 180
13.6 AUTHOR DETAILS 181

LIST OF TABLES

TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2017 VS. 2045 41
TABLE 2 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 46
TABLE 3 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 47
TABLE 4 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 47
TABLE 5 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 6 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 49
TABLE 7 TESTING STRIPS MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 8 TESTING STRIPS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 50
TABLE 9 LANCING DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 10 LANCING DEVICES MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 51
TABLE 11 LANCETS MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 12 LANCETS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 52
TABLE 13 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 53
TABLE 14 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 53
TABLE 15 SENSORS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 54
TABLE 16 SENSORS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 54
TABLE 17 TRANSMITTERS MARKET, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 18 TRANSMITTERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 55
TABLE 19 RECEIVERS MARKET, BY REGION, 2015–2022 (USD MILLION) 56
TABLE 20 RECEIVERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS) 56
TABLE 21 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2015–2022 (USD MILLION) 58
TABLE 22 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR FINGERTIP TESTING,
BY REGION, 2015–2022 (USD MILLION) 59
TABLE 23 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR ALTERNATE SITE TESTING, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 24 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 62
TABLE 25 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOME/SELF CARE,
BY REGION, 2015–2022 (USD MILLION) 63
TABLE 26 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2015–2022 (USD MILLION) 64
TABLE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 66
TABLE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES,
BY TYPE, 2015–2022 (USD MILLION) 67
TABLE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES,
BY REGION, 2015–2022 (USD MILLION) 68
TABLE 30 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION) 68
TABLE 31 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION) 69
TABLE 32 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES,
BY TYPE, 2015–2022 (USD MILLION) 70
TABLE 33 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES,
BY REGION, 2015–2022 (USD MILLION) 70
TABLE 34 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 35 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 36 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR GESTATIONAL DIABETES, BY REGION, 2015–2022 (USD MILLION) 72
TABLE 37 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION,
2015–2022 (USD MILLION) 74
TABLE 38 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 75
TABLE 39 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY PRODUCT, 2015–2022 (USD MILLION) 77
TABLE 40 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 77
TABLE 41 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 77
TABLE 42 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 78
TABLE 43 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 78
TABLE 44 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY TESTING SITE, 2015–2022 (USD MILLION) 78
TABLE 45 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 79
TABLE 46 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 79
TABLE 47 FDA APPROVALS OF BLOOD GLUCOSE MONITORING SYSTEMS (2014–2017) 81
TABLE 48 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 81
TABLE 49 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 82
TABLE 50 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 82
TABLE 51 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 82
TABLE 52 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 83
TABLE 53 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2015–2022 (USD MILLION) 83
TABLE 54 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 83
TABLE 55 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 84
TABLE 56 QUANTITY LIMITS FOR BLOOD GLUCOSE TEST STRIPS 84
TABLE 57 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 85
TABLE 58 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 85
TABLE 59 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 85
TABLE 60 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 86
TABLE 61 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 86
TABLE 62 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 86
TABLE 63 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 87
TABLE 64 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 87
TABLE 65 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 88
TABLE 66 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 90
TABLE 67 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 90
TABLE 68 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 90
TABLE 69 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 91
TABLE 70 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 91
TABLE 71 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 91
TABLE 72 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 92
TABLE 73 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 92
TABLE 74 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 93
TABLE 75 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 93
TABLE 76 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 94
TABLE 77 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 94
TABLE 78 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 94
TABLE 79 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 95
TABLE 80 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 95
TABLE 81 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 95
TABLE 82 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 96
TABLE 83 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 97
TABLE 84 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 97
TABLE 85 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 97
TABLE 86 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 98
TABLE 87 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2015–2022 (USD MILLION) 98
TABLE 88 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 98
TABLE 89 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 99
TABLE 90 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 99
TABLE 91 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 100
TABLE 92 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 100
TABLE 93 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 100
TABLE 94 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 101
TABLE 95 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 101
TABLE 96 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 101
TABLE 97 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 102
TABLE 98 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 103
TABLE 99 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 103
TABLE 100 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 103
TABLE 101 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 104
TABLE 102 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 104
TABLE 103 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2015–2022 (USD MILLION) 104
TABLE 104 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 105
TABLE 105 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 105
TABLE 106 DIABETES PREVALENCE IN APAC, BY COUNTRY 106
TABLE 107 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 106
TABLE 108 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 107
TABLE 109 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 108
TABLE 110 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 108
TABLE 111 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 108
TABLE 112 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 109
TABLE 113 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 109
TABLE 114 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 109
TABLE 115 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 110
TABLE 116 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 110
TABLE 117 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 111
TABLE 118 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 111
TABLE 119 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 111
TABLE 120 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 112
TABLE 121 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 112
TABLE 122 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 112
TABLE 123 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 113
TABLE 124 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 113
TABLE 125 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 114
TABLE 126 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 114
TABLE 127 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 114
TABLE 128 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 115
TABLE 129 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 115
TABLE 130 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 115
TABLE 131 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 116
TABLE 132 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 117
TABLE 133 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 117
TABLE 134 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 117
TABLE 135 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 118
TABLE 136 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 118
TABLE 137 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 118
TABLE 138 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 119
TABLE 139 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 119
TABLE 140 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 120
TABLE 141 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 121
TABLE 142 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 121
TABLE 143 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (USD MILLION) 122
TABLE 144 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET,
BY COMPONENT, 2015–2022 (THOUSAND UNITS) 122
TABLE 145 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION) 122
TABLE 146 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 123
TABLE 147 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 123
TABLE 148 CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015–2017) 126
TABLE 149 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 126
TABLE 150 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (USD MILLION) 127
TABLE 151 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT,
2015–2022 (THOUSAND UNITS) 127
TABLE 152 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION) 128
TABLE 153 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS) 128
TABLE 154 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2015–2022 (USD MILLION) 128
TABLE 155 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION) 129
TABLE 156 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 129
TABLE 157 PRODUCT LAUNCHES AND APPROVALS (2014-2017) 135
TABLE 158 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS 135
TABLE 159 EXPANSIONS 136
TABLE 160 ACQUISITIONS 137


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 20
FIGURE 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS 21
FIGURE 3 SECONDARY SOURCES 22
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH 24
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 6 PRIMARY SOURCES 25
FIGURE 7 KEY INDUSTRY INSIGHTS 25
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 26
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 10 DATA TRIANGULATION METHODOLOGY 28
FIGURE 11 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE GLOBAL MARKET IN 2017 30
FIGURE 12 TESTING STRIPS TO DOMINATE THE SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT (2017) 31
FIGURE 13 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT (2017) 31
FIGURE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING (2017) 32
FIGURE 15 TYPE 2 DIABETES TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION (2017) 33
FIGURE 16 FINGERTIP TESTING TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE IN 2017 33
FIGURE 17 NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH IN THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET DURING THE FORECAST PERIOD 34
FIGURE 18 PRODUCT ENHANCEMENTS IN BLOOD GLUCOSE MONITORING SYSTEMS AND GROWING DIABETIC POPULATION ARE DRIVING MARKET GROWTH 35
FIGURE 19 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT IN 2017 35
FIGURE 20 TESTING STRIPS TO DOMINATE THE GLOBAL SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET IN 2017 36
FIGURE 21 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET IN 2017 37
FIGURE 22 SELF/HOME CARE TO COMMAND THE LARGEST MARKET SHARE IN 2017 37
FIGURE 23 TYPE 2 DIABETES TO COMMAND THE LARGEST MARKET SHARE IN 2017 38
FIGURE 24 FINGERTIP TESTING TO COMMAND THE LARGEST MARKET SHARE IN 2017 38
FIGURE 25 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 39
FIGURE 26 CONTINUOUS GLUCOSE MONITORING SYSTEMS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 46
FIGURE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE,
2017 VS. 2022 (USD MILLION) 58
FIGURE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING 62
FIGURE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION,
2017 VS. 2022 (USD MILLION) 66
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017 74
FIGURE 31 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT 76
FIGURE 32 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT 89
FIGURE 33 DIABETES UK: FUNDS RAISED VS. FUNDS INVESTED 96
FIGURE 34 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT 107
FIGURE 35 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT 124
FIGURE 36 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET SHARE,
BY KEY PLAYER, 2016 130
FIGURE 37 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE,
BY KEY PLAYER, 2016 132
FIGURE 38 STRATEGIES ADOPTED BY MARKET PLAYERS (2014–2017) 134
FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016) 138
FIGURE 40 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2016) 141
FIGURE 41 DEXCOM: COMPANY SNAPSHOT (2016) 148
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2016) 152
FIGURE 43 YPSOMED: COMPANY SNAPSHOT (2016) 155
FIGURE 44 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2016) 157
FIGURE 45 NIPRO: COMPANY SNAPSHOT (2016) 159
FIGURE 46 SANOFI: COMPANY SNAPSHOT (2016) 161


[보고서에 포함된 내용]
세계시장규모, 세그멘트별 시장규모, 시장동향, 시장예측, 관련 기업정보 등

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) – Global Forecast to 2022]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆